These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 34745996)

  • 1. Neoadjuvant Chemotherapy Followed by Radiofrequency Ablation Prolongs Survival for Ablatable Colorectal Liver Metastasis: A Propensity Score Matching Comparative Study.
    Chen Y; Xu Y; Xu L; Han F; Huang Y; Jiang H; Wu J; Zhang Y
    Front Oncol; 2021; 11():758552. PubMed ID: 34745996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neoadjuvant Chemotherapy Followed by Radiofrequency Ablation May Be a New Treatment Modality for Colorectal Liver Metastasis: A Propensity Score Matching Comparative Study.
    Chen Y; Huang Y; Xu L; Wu J; Han F; Jiang H; Zheng P; Xu D; Zhang Y
    Cancers (Basel); 2022 Oct; 14(21):. PubMed ID: 36358739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repeat Local Treatment of Recurrent Colorectal Liver Metastases, the Role of Neoadjuvant Chemotherapy: An Amsterdam Colorectal Liver Met Registry (AmCORE) Based Study.
    Dijkstra M; Nieuwenhuizen S; Puijk RS; Timmer FEF; Geboers B; Schouten EAC; Opperman J; Scheffer HJ; de Vries JJJ; Versteeg KS; Lissenberg-Witte BI; Meijerink MR; van den Tol MP
    Cancers (Basel); 2021 Oct; 13(19):. PubMed ID: 34638481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncological outcomes and predictors of radiofrequency ablation of colorectal cancer liver metastases.
    Wang CZ; Yan GX; Xin H; Liu ZY
    World J Gastrointest Oncol; 2020 Sep; 12(9):1044-1055. PubMed ID: 33005297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the therapeutic efficacy between systemic chemotherapy with and without radiofrequency ablation for colorectal cancer liver metastases: A propensity score matching study.
    Hao W; Jun Z; Yan L; Zhong-Yi Z; Bin-Bin J; Gui-Ju L; Wei Y; Lin S; Kun Y
    Br J Radiol; 2023 Aug; 96(1148):20221195. PubMed ID: 37191629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neoadjuvant chemotherapy improves overall survival in resectable colorectal liver metastases patients with high clinical risk scores-- A retrospective, propensity score matching analysis.
    Chen FL; Wang YY; Liu W; Xing BC
    Front Oncol; 2022; 12():973418. PubMed ID: 36132151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary Tumor Sidedness, RAS and BRAF Mutations and MSI Status as Prognostic Factors in Patients with Colorectal Liver Metastases Treated with Surgery and Thermal Ablation: Results from the Amsterdam Colorectal Liver Met Registry (AmCORE).
    Dijkstra M; Nieuwenhuizen S; Puijk RS; Timmer FEF; Geboers B; Schouten EAC; Opperman J; Scheffer HJ; de Vries JJJ; Versteeg KS; Lissenberg-Witte BI; van den Tol MP; Meijerink MR
    Biomedicines; 2021 Aug; 9(8):. PubMed ID: 34440165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thermal Ablation Compared to Partial Hepatectomy for Recurrent Colorectal Liver Metastases: An Amsterdam Colorectal Liver Met Registry (AmCORE) Based Study.
    Dijkstra M; Nieuwenhuizen S; Puijk RS; Timmer FEF; Geboers B; Schouten EAC; Opperman J; Scheffer HJ; Vries JJJ; Swijnenburg RJ; Versteeg KS; Lissenberg-Witte BI; van den Tol MP; Meijerink MR
    Cancers (Basel); 2021 Jun; 13(11):. PubMed ID: 34199556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous radiofrequency ablation of solitary hepatic metastases from colorectal cancer: risk factors of local tumor progression-free survival and overall survival.
    Lee HJ; Lee MW; Ahn SH; Cha DI; Ko SE; Kang TW; Song KD; Rhim H
    Ultrasonography; 2022 Oct; 41(4):728-739. PubMed ID: 35909318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nomogram including chemotherapy response for prediction of intrahepatic progression-free survival in patients with colorectal liver metastasis through chemotherapy followed by radiofrequency ablation.
    Wu H; Liu GJ; Zhang ZY; Wu W; Meng YF; Wang S; Yang W; Yan K
    Int J Hyperthermia; 2021; 38(1):633-639. PubMed ID: 33882789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From the completion of neoadjuvant chemotherapy to surgery for colorectal cancer liver metastasis: What is the optimal timing?
    Chen Q; Mao R; Zhao J; Bi X; Li Z; Huang Z; Zhang Y; Zhou J; Zhao H; Cai J
    Cancer Med; 2020 Nov; 9(21):7849-7862. PubMed ID: 32886456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival Evidence of Local Control for Colorectal Cancer Liver Metastases by Hepatectomy and/or Radiofrequency Ablation.
    Canseco LM; Liu YW; Lu CC; Lee KC; Chen HH; Hu WH; Tsai KL; Yang YH; Wang CC; Hung CH
    Cancers (Basel); 2023 Sep; 15(18):. PubMed ID: 37760404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatectomy vs radiofrequency ablation for colorectal liver metastasis: a propensity score analysis.
    Lee H; Heo JS; Cho YB; Yun SH; Kim HC; Lee WY; Choi SH; Choi DW
    World J Gastroenterol; 2015 Mar; 21(11):3300-7. PubMed ID: 25805937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multielectrode Radiofrequency Ablation for Resectable Metachronous Liver Metastasis from Colorectal Cancer.
    Cheng HY; Huang KW; Liang JT; Lin BR; Huang J; Hung JS; Chen CL
    J Clin Med; 2021 Aug; 10(16):. PubMed ID: 34442007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognosis of radiofrequency ablation versus hepatic resection for patients with colorectal liver metastases: A systematic review and meta-analysis based on 22 studies.
    Yang G; Wang G; Sun J; Xiong Y; Li W; Tang T; Li J
    Int J Surg; 2021 Mar; 87():105896. PubMed ID: 33588125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Single-Center Retrospective Analysis of Periprocedural Variables Affecting Local Tumor Progression after Radiofrequency Ablation of Colorectal Cancer Liver Metastases.
    Han K; Kim JH; Yang SG; Park SH; Choi HK; Chun SY; Kim PN; Park J; Lee M
    Radiology; 2021 Jan; 298(1):212-218. PubMed ID: 33170105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved Outcomes of Thermal Ablation for Colorectal Liver Metastases: A 10-Year Analysis from the Prospective Amsterdam CORE Registry (AmCORE).
    Puijk RS; Dijkstra M; van den Bemd BAT; Ruarus AH; Nieuwenhuizen S; Geboers B; Timmer FEF; Schouten EAC; de Vries JJJ; van der Meijs BB; Nielsen K; Swijnenburg RJ; van den Tol MP; Versteeg KS; Lissenberg-Witte BI; Scheffer HJ; Meijerink MR
    Cardiovasc Intervent Radiol; 2022 Aug; 45(8):1074-1089. PubMed ID: 35585138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neoadjuvant Chemotherapy Versus Upfront Surgery for Resectable Liver Metastases from Colorectal Cancer: a Multicenter, Propensity Score-Matched Cohort Study.
    Hirokawa F; Ueno M; Nakai T; Kaibori M; Nomi T; Iida H; Tanaka S; Komeda K; Hayami S; Kosaka H; Hokuto D; Kubo S; Uchiyama K
    J Gastrointest Surg; 2022 Apr; 26(4):772-781. PubMed ID: 34664190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative study on prognosis of neoadjuvant chemotherapy followed by hepatic surgery versus upfront surgery in patients with synchronous colorectal liver metastasis].
    Wang LJ; Wang HW; Jin KM; Liu W; Bao Q; Wang K; Xing BC
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Mar; 24(3):248-255. PubMed ID: 34645169
    [No Abstract]   [Full Text] [Related]  

  • 20. Oncological outcomes of neoadjuvant chemotherapy in patients with resectable synchronous colorectal liver metastasis: A result from a propensity score matching study.
    Jiang YJ; Zhou SC; Chen JH; Liang JW
    Front Oncol; 2022; 12():951540. PubMed ID: 36330479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.